Govt job: For Ph.D, M.Pharm, M.Sc under Ministry of S & T | Salary upto Rs. 1,50,000 pm

Institute of Life Sciences (ILS), Bhubaneswar is a leading national institute in India. It is a multidisciplinary institute engaged in advanced research in Infectious Disease Biology, Cancer Biology, Genetics & Autoimmune Diseases, and Plant & Microbial Biotechnology.

Post : Project Associate-I/NGS Data Analyst, Lab Technician, Quality control consultant / Research Associate

Position : 1 Project Associate-I / NGS Data Analyst (1)

Project Title :  Documentation and Validation of Traditional Healthcare Knowledge of Indian Himalayan Region: Translational approach

Remuneration : Rs.31,000/- + @ 16% HRA per month

Eligibility Criteria : Candidates having M.Sc. / M. Tech / M. Pharm. / M.V.Sc. or equivalent qualification in Life Sciences or allied subjects (Biochemistry/ Biotechnology/ Bioinformatics/ computational Biology, Microbiology etc.) with a minimum of 60% aggregate marks (relaxation will be given as per GOI guideline) are eligible to apply. Candidate having experience in Next Generation Sequencing (NGS) data analysis and working knowledge of Linux, Python and R will be given preference.

Preference will be given to national level entrance test (NET/GATE/GPAT) qualified candidates. For non-NET/GATE candidates, the fellowship would be applicable as per DST guidelines.

Age Limit : The upper age limit of the candidate should be below 35 years as on last date of application. Age relaxation will be given to the candidates as per Govt. of India rules.

Position : 2 Lab Technician (1)

Project Title : Documentation and Validation of Traditional Healthcare Knowledge of Indian Himalayan Region: Translational approach.

Remuneration : Rs.20,000/- + @ 16% HRA per monthEligibility Criteria : B.Sc. in any branch of Life Science. Candidates having working experience in Biological research laboratories and DMLT qualification will be preferred.

Position : 3 Quality control consultant / Research Associate (2)

Project Title : Establish state of the art clinical-immunogenicity assay platform to facilitate COVID-19 vaccine development.

Remuneration : Rs. 1,50,000/- per month (consolidated) (negotiable based on experience).

Eligibility Criteria : M.Sc. / Ph.D. in any branch of Biological Science/ Life Science with minimum 5 years of research experience.

Desirable : Experience in assessing and guiding on the quality assessment parameters of assays, report generation, SOP generation, documentation and application for ISO and NABL accreditation. Candidates with Ph.D. in Immunology or extensive expertise in Immunological techniques like Flow Cytometry, ELISA and cell culture will be preferred.

Age Limit : The upper age limit of the candidate should be below 50 years as on last date of application. Age relaxation will be given to the candidates as per Govt. of India rules.

Selection will be carried out through application screening, followed by an interview process.

Interested/eligible candidates may download application form from the institute website (ils.res.in ) and apply along with self-attested copies of mark sheets, certificates and other relevant documents to the “Director, Institute of Life Sciences, Nalco Square, Bhubaneswar-751023.” Super-scribe the envelope with “Position No…… and Application for the position of ………..” N.B.:

The list of shortlisted candidates name and the date of interview will be published on the ILS website. All the positions are purely temporary and coterminous with the project. No TA/DA will be paid for attending the interview.

The decision of the Director regarding selection of candidates will be final and no further correspondence will be entertained in this regard.

Note : All communication will be through e-mail. No separate call letter will be issued to the candidates.

Last date of receipt of application :17.05.2022

Date of publishing the name of shortlisted candidates on the website : 20.05.2022

Related Posts

  • Pharma
  • April 19, 2024
  • 24 views
US FDA Mandates Label Updates On CAR-T Cancer Therapies

Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

  • Pharma
  • April 19, 2024
  • 15 views
Karnataka Fails To Take Action Against 1,700 Fake Doctors

Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Mandates Label Updates On CAR-T Cancer Therapies

US FDA Mandates Label Updates On CAR-T Cancer Therapies

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs